fbpx Skip to main content

MONDAY, Aug. 31, 2020 (HealthDay News) — Many children may have delayed diagnosis of type 1 diabetes during the COVID-19 pandemic, according to a study published online Aug. 10 in Diabetes Care.

Ivana Rabbone, M.D., Ph.D., from the University of Piemonte Orientale in Novara, Italy, and colleagues surveyed all Italian pediatric diabetes centers to collect diabetes, diabetic ketoacidosis (DKA), and COVID-19 data for patients presenting with new-onset or established type 1 diabetes between Feb. 20 and April 14 for both 2019 and 2020.

The researchers found that based on responses from 53 centers, there was a 23 percent reduction in new diabetes cases in 2020 versus 2019. Of newly diagnosed patients who presented in a state of DKA, the proportion with severe DKA was higher in 2020 (44.3 percent in 2020 versus 36.1 percent in 2019). Rates of acute complications were similar between the two years.

“The COVID-19 pandemic might have altered diabetes presentation and DKA severity,” the authors write. “Preparing for any ‘second wave’ requires strategies to educate and reassure parents about timely emergency department attendance for non-COVID-19 symptoms.”

Abstract/Full Text (subscription or payment may be required)

You May Also Like::  Fracking Activity May Up Heart Failure Hospitalization Risk

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More